| Colinz Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531210 |
NSE Symbol : - |
P/E(TTM) : 61.29 |
|
ISIN Demat : INE923C01011 |
Div & Yield% : - |
EPS(TTM) : 1.17 |
|
Book Value(₹) : 24.94 |
Market Cap(₹Cr) : 32.78 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 1.86 | 1.75 | 1.63 | 1.71 | 1.79 | 1.90 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.86 | 1.75 | 1.63 | 1.71 | 1.79 | 1.90 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.08 | 0.07 | 0.11 | 0.05 | 0.08 | 0.04 |
| Total Income | 1.94 | 1.81 | 1.74 | 1.76 | 1.86 | 1.94 |
| Total Expenditure | 1.69 | 1.59 | 1.50 | 1.57 | 1.66 | 1.75 |
| PBIDT | 0.25 | 0.23 | 0.23 | 0.19 | 0.20 | 0.19 |
| Interest | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| PBDT | 0.24 | 0.22 | 0.22 | 0.18 | 0.19 | 0.19 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Tax | 0.05 | 0.05 | 0.07 | 0.04 | 0.04 | 0.03 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.16 | 0.14 | 0.14 | 0.11 | 0.12 | 0.12 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.16 | 0.14 | 0.14 | 0.11 | 0.12 | 0.12 |
| EPS (Unit Curr.) | 0.62 | 0.54 | 0.54 | 0.42 | 0.49 | 0.48 |
| EPS (Adj) (Unit Curr.) | 0.62 | 0.54 | 0.54 | 0.42 | 0.49 | 0.48 |
| Calculated EPS (Unit Curr.) | 0.62 | 0.54 | 0.54 | 0.42 | 0.49 | 0.48 |
| Calculated EPS (Adj) (Unit Curr.) | 0.62 | 0.54 | 0.54 | 0.42 | 0.49 | 0.48 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.47 | 2.18 | 2.16 | 1.69 | 1.96 | 1.92 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.47 | 2.18 | 2.16 | 1.69 | 1.96 | 1.92 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 | 2.52 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.44 | 13.14 | 14.11 | 11.11 | 11.17 | 10.00 |
| PBDTM(%) | 12.90 | 12.57 | 13.50 | 10.53 | 10.61 | 10.00 |
| PATM(%) | 8.60 | 8.00 | 8.59 | 6.43 | 6.70 | 6.32 |